• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Pathog . TMPRSS2 reduces antibody recognition of SARS-CoV-2 spike

tetano

Editor, Senior Moderator
PLoS Pathog

. 2026 Nov 17;22(11):e1014799.
doi: 10.1371/journal.ppat.1014799. Online ahead of print.

TMPRSS2 reduces antibody recognition of SARS-CoV-2 spike​


Andrea Cottignies-Calamarte 1 2 , Alejandro De Cruz 1 2 , Cyril Planchais 3 , Françoise Porrot 2 , Daphné Rageot 1 2 3 , Irène Misguich 1 2 , Mateo Kryzpow 1 2 , Martin Jungbauer-Groznica 1 2 , Eva Thuillier 2 , Amelie Wileveau 2 , Isabelle Staropoli 2 , Florence Guivel-Benhassine 2 , Pierre Rosenbaum 4 , Ignacio Fernández 5 , Felix Rey 5 , Julian Buschrieser 2 , Sophie Trouillet-Assant 6 7 , Hugo Mouquet 4 , Olivier Schwartz 2 8 , Timothée Bruel 1 2 8

Affiliations Expand

Free article

Abstract​


The serine protease TMPRSS2 acts as a cofactor for SARS-CoV-2 entry by cleaving the viral spike (S) to initiate fusion. Whether TMPRSS2 has an impact on humoral immune response against S remains poorly characterized. Here, we show that TMPRSS2 impairs antibody binding to S. In S-expressing and infected cells, TMPRSS2 decreases monoclonal antibody (mAb) and immune serum binding, as well as antibody-dependent cellular cytotoxicity (ADCC) induction. Using a panel of 39 mAbs targeting various S regions, we observe that those binding to the S2 subunit are the most affected by TMPRSS2. TMPRSS2 promotes a partial shedding of S1 and changes S2 conformation. This processing reduces Angiotensin-Converting Enzyme 2 (ACE2) binding while increasing cell-cell fusion. We further observe that the capacity of TMPRSS2 to decrease antibody recognition is conserved across coronaviruses and shared with other TMPRSS proteins. However, TMPRSS2 expression in infected cells does not impact significantly virions' infectivity or the antibody recognition, as measured by flow virometry. Collectively, our findings suggest that TMPRSS2 processing of S favors a conformation which is less sensitive to antibody recognition.
 
Back
Top Bottom